Epilepsy Market: Current Analysis and Forecast (2022-2028)

Report Description

The Epilepsy market was valued at USD 7 Billion and is expected to grow with a CAGR of 3.5% during the forecast period (2022-2028). The product approvals by the key players for the treatment of seizures are propelling the market demand for the seizure market. For instance, in 2020, UCB S.A., a global pharmaceutical company announced the USFDA approval for VIMPAT (lacosamide) CV as an adjuvant therapy in treatment for generalized tonic-clonic seizures in patients four years or older. Additionally, with the growing understanding of the genetic and molecular basis of epilepsy, there is a growing trend towards personalized treatment approaches that take into account the unique characteristics of each patient. Thus, these elements are anticipated to fuel the market growth in the forecasted period.

Some of the major players operating in the market include Abbott., Novartis Pharmaceutical Corporation, GSK plc., Sanofi, Johnson & Johnson Services, Inc., UCB S.A., Sumitomo Pharma Co., Ltd., Bausch Health Companies Inc., H. Lundbeck A/S, Pfizer Inc.

Insights Presented in the Report

“Amongst seizure type, the non-epileptic seizure segment is growing with significant CAGR in 2021 market”

Based on type, the market is segmented into focal seizure, generalized seizure and non-epileptic seizure. Amongst these the non-epileptic seizure is anticipated to grow with a significant CAGR in the forecasted period. This is due to the rising incidence of non-epileptic seizures. Seizers that are not due to the activity are termed non-epileptic seizures. Additionally, the factors such as psychological, environmental, hypoglycemia and other medical conditions. These factors contribute towards non-epileptic activity. Further, For instance, according to the United Kingdom 2020 report, around 1 in 5 people (20%) diagnosed with epilepsy who are then assessed at specialist epilepsy centres are found to have NES. Thus, these above-mentioned elements are anticipated to fuel the market growth.

“Amongst drug generation, the third generation segment is growing with a significant CAGR in the market in 2021”

Based on the generation type the market is segmented into first generation, second generation and third generation. Amongst these, the third-generation segment is anticipated to grow with a significant CAGR in the forecasting period.

This is attributed towards its high efficacy and potency. The third generations are highly effective in controlling seizures, including drug resistance seizures and is used in patients with seizures who don’t respond effectively to first and second-generation medications.

Epilepsy Market Report Coverage

“Amongst end-users, the clinic segment is growing with a significant CAGR in the market in 2021”

Based on the end-users the market is segmented into hospitals, clinics, research institutes and diagnostic centres. Amongst these, the clinic segment is anticipated to grow with a significant CAGR. This is attributed to the demand for cost-effective and personalized care. Clinics may be able to provide more personalized care because they have smaller patient volumes and may be able to spend more time with each patient. This can be especially important for people with epilepsy, who may require ongoing monitoring and management of their conditions. Additionally, some clinics may be better equipped to provide a positive patient experience, with a focus on patient-centred care and a more personalized approach to care. This can be important for people with epilepsy, who may be dealing with a chronic condition and may require ongoing support and guidance from their healthcare providers. Thus, these factors are anticipated to fuel the market growth for epilepsy in the near future.

“North America is anticipated to grow with significant CAGR of the epilepsy market in 2021”

North America is anticipated to grow with a significant CAGR in the 2021 market. This is attributed towards the rising incidence of Epilepsy in this region. For instance, according to the WHO 2023 report, around 49 per 100 000 people are diagnosed with epilepsy each year, including those living in high-income countries. Additionally, factors such as injury, and trauma have significantly contributed towards the growth of these segments. Thus, these above-mentioned factors are anticipated to propel the market growth in the forecasting period.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The global epilepsy market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the Epilepsy Market Analysis (2022-2028)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global epilepsy market were the three major steps undertaken to create and analyze the adoption of epilepsy in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global epilepsy market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the epilepsy market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the epilepsy market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as seizure type, generation type and end-users. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the epilepsy market. Further, we conducted factor analysis using dependent and independent variables such as seizure type, generation type and end-users of the epilepsy market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the epilepsy market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global epilepsy market, and market shares of the segments. All the required percentage shares split and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the Epilepsy  market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the global epilepsy market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global epilepsy market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of disorder type, and service type in the global epilepsy market.

The main objective of the Global Epilepsy Market Study

The current & future market trends of the global epilepsy market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of the epilepsy market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
• Segments in the study include areas of the type of seizures, generation types and end-users
• Define and analysis of the regulatory framework for the epilepsy industry
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
• Analyze the current and forecast market size of the epilepsy market for the major region
• Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
• Company profiles of the epilepsy market and the growth strategies adopted by the market players to sustain in the fast-growing market
• Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team